1. Home
  2. NOA vs PHAT Comparison

NOA vs PHAT Comparison

Compare NOA & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOA
  • PHAT
  • Stock Information
  • Founded
  • NOA 1953
  • PHAT 2018
  • Country
  • NOA Canada
  • PHAT United States
  • Employees
  • NOA N/A
  • PHAT N/A
  • Industry
  • NOA Meat/Poultry/Fish
  • PHAT Biotechnology: Pharmaceutical Preparations
  • Sector
  • NOA Consumer Staples
  • PHAT Health Care
  • Exchange
  • NOA Nasdaq
  • PHAT Nasdaq
  • Market Cap
  • NOA 556.4M
  • PHAT 465.0M
  • IPO Year
  • NOA 2006
  • PHAT 2019
  • Fundamental
  • Price
  • NOA $18.48
  • PHAT $5.67
  • Analyst Decision
  • NOA
  • PHAT Strong Buy
  • Analyst Count
  • NOA 0
  • PHAT 4
  • Target Price
  • NOA N/A
  • PHAT $23.00
  • AVG Volume (30 Days)
  • NOA 52.3K
  • PHAT 1.0M
  • Earning Date
  • NOA 03-05-2025
  • PHAT 03-06-2025
  • Dividend Yield
  • NOA 1.65%
  • PHAT N/A
  • EPS Growth
  • NOA N/A
  • PHAT N/A
  • EPS
  • NOA 1.41
  • PHAT N/A
  • Revenue
  • NOA $874,213,701.00
  • PHAT $26,270,000.00
  • Revenue This Year
  • NOA $25.68
  • PHAT $7,453.23
  • Revenue Next Year
  • NOA $8.31
  • PHAT $226.38
  • P/E Ratio
  • NOA $13.23
  • PHAT N/A
  • Revenue Growth
  • NOA 35.78
  • PHAT N/A
  • 52 Week Low
  • NOA $16.46
  • PHAT $5.21
  • 52 Week High
  • NOA $25.92
  • PHAT $19.71
  • Technical
  • Relative Strength Index (RSI)
  • NOA 35.18
  • PHAT 39.59
  • Support Level
  • NOA $18.59
  • PHAT $5.50
  • Resistance Level
  • NOA $19.17
  • PHAT $6.21
  • Average True Range (ATR)
  • NOA 0.44
  • PHAT 0.40
  • MACD
  • NOA 0.01
  • PHAT 0.07
  • Stochastic Oscillator
  • NOA 32.54
  • PHAT 38.69

About NOA North American Construction Group Ltd. (no par)

North American Construction Group Ltd is Canada's heavy civil construction and mining contractor provider. The company has provided services to oil, natural gas, and resource companies. The Company provides a wide range of mining and heavy civil construction services to customer in the resource development and industrial construction sectors within Canada, the United States, and Australia. The Company's reportable segments are Heavy Equipment - Canada, Heavy Equipment - Australia, and Other. Heavy Equipment - Canada and Heavy Equipment - Australia include all of aspects of the mining and heavy civil construction services provided within those geographic areas. Other includes our mine management contract work in the United States, its external maintenance and rebuild programs.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: